Hybrid Coronary Revascularization Trial

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 9, 2017

Primary Completion Date

March 31, 2021

Study Completion Date

September 30, 2021

Conditions
Coronary Artery Disease
Interventions
PROCEDURE

Hybrid Coronary Revascularization (isolated LIMA-LAD)

sternal-sparing, off-pump, isolated LIMA-LAD revascularization

DEVICE

Hybrid Coronary Revascularization (PCI)

percutaneous revascularization of at least one non-LAD target

DEVICE

Percutaneous Coronary Intervention

Multi-vessel PCI with metallic drug-eluting stents (DES) including the LAD and or LM. Only FDA approved commercially available metallic drug-eluting stents may be used in this protocol.

Trial Locations (46)

10003

Mount Sinai Beth Israel, New York

10032

Columbia University Medical Center/New York Presbyterian Hospital, New York

10075

Lenox Hill Hospital, New York

10461

Montefiore - Einstein, The Bronx

13203

St. Joseph's Hospital Health Center, Syracuse

14203

Buffalo General Medical Center/Gates Vascular Institute, Buffalo

15212

Allegheny General Hospital, Pittsburgh

17104

Pinnacle Health Cardiovascular System, Harrisburg

19096

Lankenau Medical Center, Wynnewood

19104

University of Pennsylvania, Philadelphia

19141

Einstein Healthcare Network, Philadelphia

19611

The Reading Health System, West Reading

20742

University of Maryland, College Park

22042

Inova Fairfax Medical Campus, Falls Church

22903

University of Virginia, Charlottesville

27157

Wake Forest Baptist Medical Center, Winston-Salem

27610

WakeMed Health and Hospitals, Raleigh

27710

Duke University, Durham

29425

Medical University of South Carolina, Charleston

30308

Emory University Hospital Midtown, Atlanta

32806

Orlando Health Heart Institute, Orlando

33908

HealthPark Lee Memorial Health Systems, Fort Myers

37403

Erlanger Health System, Chattanooga

43210

Ohio State University, Columbus

43614

University of Toledo Medical Center, Toledo

52242

University of Iowa, Iowa City

53706

University of Wisconsin, Madison

54601

Gundersen Health System, La Crosse

55455

Universty of Minnesota, Minneapolis

60637

University of Chicago Medical Center, Chicago

75093

Baylor Research Institute at The Heart Hospital Baylor Plano, Plano

77030

Houston Methodist Hospital, Houston

90033

University of Southern California, Los Angeles

90048

Cedars-Sinai Medical Center, Los Angeles

90095

University of California Los Angeles, Los Angeles

90806

Long Beach Memorial Medical Center, Long Beach

94305

Stanford University, Stanford

06510

Yale University, New Haven

08103

Our Lady of Lourdes Medical Center, Camden

T6G 2R3

University of Alberta, Edmonton

V5Z 1M9

Vancouver General Hospital, Vancouver

Unknown

London Health Sciences Centre, London

Centre Intégré Universitaire/Sacre Coeur, Montreal

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

M5B 1W8

St Michael's Hospital, Toronto

H3T 1E2

Jewish General Hospital, Montreal

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Emilia Bagiella

OTHER

NCT03089398 - Hybrid Coronary Revascularization Trial | Biotech Hunter | Biotech Hunter